Right-sided Infective Endocarditis

• FDA approval · 2023-09-19
  FDA Approved: DAPTOMYCIN — Supplemental Application (Sagent Pharmaceuticals)

  The FDA approved a supplemental application for daptomycin filed by Sagent Pharmaceuticals (ANDA 207104), resulting in an approved regulator…

• FDA approval · 2019-08-22
  FDA Approved: DAPTOMYCIN — Original Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved Hikma Pharmaceuticals USA Inc.'s generic daptomycin under an Original Application. The approval covers the same indications as …

• CLINICAL_TRIALS withdrawal · 2011-09-28
  Clinical Trial Update: Safety and Efficacy Study of CUBICIN (Daptomycin) Under Conditions of Actual Use

  A study evaluating the safety and efficacy of Cubicin (daptomycin) under real-use conditions has been withdrawn.